| Entry |
|
|---|
| Name |
Amezinium metilsulfate (JAN);
Risumic (TN) |
|---|
| Formula |
C11H12N3O. CH3SO4
|
|---|
| Exact mass |
313.0732
|
|---|
| Mol weight |
313.3296
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
|
|---|
| Remark |
| Therapeutic category: | 2190 |
|
|---|
| Efficacy |
Antihypotensive, Noradrenaline reuptake inhibitor |
|---|
| Comment |
Pyridazine derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA25 Amezinium metilsulfate
D01304 Amezinium metilsulfate (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D01304 Amezinium metilsulfate (JAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
D01304 Amezinium metilsulfate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D01304 Amezinium metilsulfate (JAN) <JP>
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C8x C 19.2675 -15.5914
2 C8y C 19.2675 -16.9909
3 C8x C 20.4825 -17.6907
4 C8x C 21.6903 -16.9909
5 C8x C 21.6903 -15.5914
6 C8x C 20.4825 -14.8916
7 N5y N 18.0558 -17.6914 #+
8 C8y C 16.8462 -16.9886
9 C8x C 15.6345 -17.6890
10 C8y C 15.6353 -19.0886
11 C8x C 16.8477 -19.7877
12 N5x N 18.0593 -19.0874
13 O2a O 16.8477 -15.3790
14 N1a N 14.4236 -19.7890
15 C1a C 18.0605 -14.6806
16 S4a S 26.7406 -17.6792
17 O2a O 25.3541 -17.6792
18 O1d O 26.7347 -16.0588
19 O1d O 26.7347 -19.0363
20 O1d O 28.0275 -17.6792 #-
21 C1a C 24.1726 -17.0006
BOND 21
1 7 8 2
2 8 9 1
3 9 10 2
4 10 11 1
5 11 12 2
6 12 7 1
7 5 6 2
8 8 13 1
9 6 1 1
10 10 14 1
11 13 15 1
12 2 7 1
13 1 2 2
14 2 3 1
15 3 4 2
16 4 5 1
17 16 17 1
18 16 18 2
19 16 19 2
20 16 20 1
21 17 21 1
|
|---|
